Skip to content

Re-invitation to Screening Colonoscopy: a Randomized Study

Re-invitation to Screening Colonoscopy: a Randomized Controlled Trial of Reminding Letter and Educational Intervention on Attendance in Nonresponders to Initial Invitation to Screening Colonoscopy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01183156
Acronym
REINVITE
Enrollment
1000
Registered
2010-08-17
Start date
2010-08-31
Completion date
2011-03-31
Last updated
2011-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Patient Participation, Screening

Keywords

Colorectal Cancer, Screening, Colonoscopy, Attendance, Participation

Brief summary

The aim of this study is to compare the effect of reminding letter and educational intervention on attendance to screening colonoscopy in nonresponders to initial invitation to screening colonoscopy.

Detailed description

NordICC (The NordICC Initiative on Colorectal Cancer, NCT00883792) is a multicenter randomised trial to investigate the effect of screening colonoscopy on CRC incidence and mortality. In Poland, in Warsaw area, at least 10,000 subjects 55-64 years of age are to be invited to screening colonoscopy. A personal letter of invitation containing date and hour of appointment is mailed to every individual randomised to the screening group. Up to 60% of invitees do not respond to the initial invitation and reminding letter. The aim of this study is to compare the effect of reminding letter and educational intervention on attendance to screening colonoscopy in nonresponders to initial invitation to screening colonoscopy.

Interventions

BEHAVIORALRe-invitation letter

Re-invitation letter sent 6 weeks prior to prespecified screening colonoscopy appointment date and followed by reminder letter within 3 weeks if no response is received.

BEHAVIORALInvitation to educational meeting

Invitation will be sent 6 weeks prior to educational meeting date and followed by a reminding letter 3 weeks later. Educational meetings will be held in a local culture developement centers and conducted by a medical team responsible for the Polish Colorectal Cancer Screening Program. The aim of the meeting is to overcome barriers to screening colonoscopy. The program of the meeting is tailored to individual needs, doubts, and concerns of the participating group as assessed using brief survey at the beginning of the meeting. The major points to be discussed are: risk and benefit of screening, colorectal cancer risk, pain and sedation, preparation to colonoscopy, consecutive stages of the procedure, comfort and embarrassment.

Sponsors

National Center for Research and Development, Poland
CollaboratorOTHER
Maria Sklodowska-Curie National Research Institute of Oncology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Men and women 55-64 years of age invited for screening colonoscopy within the NordICC trial (NCT00883792) in Poland, who have not responded to the first invitation.

Exclusion criteria

* Resident abroad * Return of unopened letter of invitation and/or reminder (address unknown) * Message from neighbour/family/post office on death of screenee (not updated in Population Registry).

Design outcomes

Primary

MeasureTime frameDescription
Attendance to screening colonoscopy6 months from the date of re-invitation or invitation to educational meetingPercentage of invitees attending screening colonoscopy

Secondary

MeasureTime frameDescription
Response rate to the re-invitation letter or invitation to the educational meeting3 months from the date of reinvitation letter or date of invitation to the educational meetingPercentage of invitees sending back reply form

Countries

Poland

Contacts

Primary ContactPisera Malgorzata
mpisera@coi.waw.pl+48225463056
Backup ContactKaminski Michal
mfkaminski@coi.waw.pl+48225463058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026